SCHEMBL20109258

SCHEMBL20109258

C=C(C(Cc1ccccc1-c1ccccc1)C(=O)OCC)P1(=N)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.39
SLC6A2 P23975 6/20 0.38
SLC6A4 P31645 6/20 0.38
CYP2D6 P10635 4/20 0.38
SLC6A3 Q01959 4/20 0.38
KCNH2 Q12809 2/20 0.38
CHRM3 P20309 1/20 0.38
MMP8 P22894 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
MME P08473 1/20 0.34
ACE P12821 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109146 0.90 KMT2A (0.46) KMT2ALMNASLC6A2SLC6A4CYP2D6
SCHEMBL21866414 0.89 KMT2A (0.45) KMT2ALMNASLC6A2SLC6A4CYP2D6
SCHEMBL20113547 0.85 MMP8 (0.49) MMP8ALDH1A1CYP1A2GAACYP2C9
SCHEMBL20109247 0.82 MMP8 (0.44) KMT2AMMP8MEN1ALDH1A1CYP1A2
SCHEMBL20109221 0.82 KMT2A (0.46) KMT2ALMNASLC6A2SLC6A4CYP2D6
SCHEMBL20113631 0.81 ALDH1A1 (0.43) KMT2AMMP8MEN1ALDH1A1GAA
SCHEMBL20113465 0.81 MMP8 (0.42) KMT2ALMNAMMP8KDM4EMEN1
SCHEMBL20113534 0.80 OPRD1 (0.36) KMT2ALMNAMMP8MEN1ALDH1A1
SCHEMBL20113538 0.79 ALDH1A1 (0.39) KMT2ALMNAMEN1ALDH1A1CYP1A2
SCHEMBL20113634 0.79 MMP8 (0.38) KMT2AMMP8KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633403-B2 N-heterocyclic phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA (US) 2020-04-28 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 KMT2A 2508/4885LMNA 3601/4885SLC6A2 1467/4885
US-10633403-B2 N-heterocyclic phosphines NANP, PPIP5K2, PHPT1 KMT2A 2508/4885LMNA 3601/4885SLC6A2 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.